For newborns and neonates, NOxBOXi Nitric Oxide Delivery System is recalled.

Published Date: 20 Jul 2023

The NOxBOXi Nitric Oxide Delivery System recall by NOxBOX Ltd has been classified as a Class I recall by the FDA. Because of a misaligned check valve, affected devices can interrupt nitric oxide therapy in patients who are newborns and neonates. The federal agency reports that as of July 13, 2023, there have been no injuries or fatalities.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

2.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

3.

Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.

4.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer

5.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot